Initial report of KSCC0803 : feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients

Yasunori Emi,Yoshihiro Kakeji,Eiji Oki,Hiroshi Saeki,Koji Ando,Masaki Kitazono,Yoshihisa Sakaguchi,Masaru Morita,Hironori Samura,Yutaka Ogata,Yoshito Akagi,Shoji Natsugoe,Kazuo Shirouzu,Shoji Tokunaga,Florin Sirzén,Yoshihiko Maehara

Initial report of KSCC0803 : feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients

2013

Yasunori Emi
Yoshihiro Kakeji
Eiji Oki
Hiroshi Saeki
Koji Ando
Masaki Kitazono
Yoshihisa Sakaguchi
Masaru Morita
Hironori Samura
Yutaka Ogata
Yoshito Akagi
Shoji Natsugoe
Kazuo Shirouzu
Shoji Tokunaga
Florin Sirzén
Yoshihiko Maehara

Background A prospective feasibility study was planned to clarify the proportion of compliance and adverse events in the administration of capecitabine as adjuvant chemotherapy for colon cancer in Japanese patients.

Keywords:

Capecitabine
Colorectal cancer
Hematology
Adjuvant
Oncology
Stage III Colon Cancer
Chemotherapy
Internal medicine
Adverse effect
Medicine
adjuvant chemotherapy
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations